Technology area: Biotechnology & Pharmaceuticals
28 pending office actions • 26 art units • 28 examiners • 0 of 28 (0%) have an AI response strategy ready • 32 patents granted in the last 365 days
The Trustees of Indiana University has 30 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 30 examiners across 27 art units, showing that the docket is highly distributed among examiners and technical examination groups.
SARCENO ROBLES, CHRISTIAN MANUEL is the busiest examiner, with 1 pending office action. No examiner carries more than the stated single action, so coordination is more likely to depend on technology and art-unit organization than on a concentrated examiner relationship.
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 3 (11%) |
| §103 only | 7 (25%) |
| §102 only | 2 (7%) |
| §112 only | 3 (11%) |
| Double-patenting + other | 1 (4%) |
| Multi-statute (no §101) | 12 (43%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SARCENO ROBLES, CHRISTIAN MANUEL | 1 | 50.0% | +100.0% |
| LIU, TRACY | 1 | 54.5% | +26.9% |
| TROCHE, EDGAREDMANUE | 1 | 58.0% | +34.5% |
| MORAN, EDWARD JOHN | 1 | 42.0% | +61.2% |
| VASISTH, VISHAL V | 1 | 72.5% | +33.4% |
| GREENE, CAROLYN LEE | 1 | 65.7% | +46.1% |
| VO, HUYEN X | 1 | 83.4% | +19.9% |
| WELLS, LAUREN QUINLAN | 1 | 49.4% | +59.7% |
| JACKSON III, WALTER | 1 | 50.0% | +0.0% |
| AEDER, SEAN E | 1 | 56.9% | +20.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18886296 | METHOD AND APPARATUS FOR ENCODING/DECODING NEURAL NETWORK-BASED PERSONALIZED SPEECH | VO, HUYEN X | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18040834 | IN VIVO LYMPHOVENOUS ANASTOMOSIS | SHIN, DANA H | 9d |
| 17791981 | SYSTEM AND METHOD FOR PROCESSING VIRUS PREPARATIONS TO REDUCE HETEROGENEITY | SIFFORD, JEFFREY MARK | 16d |
| 18541121 | POTENTIATING THE TUMOR-SELECTIVE EFFECTS OF NQO1-BIOACTIVATABLE AGENT BY USE OF CMET INHIBITOR | ARCORIA, PAUL JOSEPH | 28d |
| 19083739 | HAND-HELD MEASUREMENT APPARATUS, SYSTEMS, AND METHODS | SARCENO ROBLES, CHRISTIAN MANUEL | — |
| 18861236 | THERAPEUTIC STRATEGIES TO MANAGE FACIAL CONTRACTURES POST INJURY | LIU, TRACY | — |
| 18927321 | SYSTEMS AND METHODS FOR MONITORING AND CONTROLLING ADDITIVE PRINTING PROCESSES | TROCHE, EDGAREDMANUE | — |
| 18890423 | MYC-HSF1 DUAL AMPLIFICATION AS A BIOMARKER FOR CANCER TREATMENT | GREENE, CAROLYN LEE | — |
| 18716889 | METHODS OF GENERATING HUMAN COCHLEAR HAIR CELLS | ZHU, JIANJIAN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18913249 | DENTAL IMPLANTS, DENTAL ASSEMBLIES, AND METHODS OF IMPLANTING AND REPAIRING DENTAL ASSEMBLIES | MORAN, EDWARD JOHN | 33d |
| 19083739 | HAND-HELD MEASUREMENT APPARATUS, SYSTEMS, AND METHODS | SARCENO ROBLES, CHRISTIAN MANUEL | — |
| 18861236 | THERAPEUTIC STRATEGIES TO MANAGE FACIAL CONTRACTURES POST INJURY | LIU, TRACY | — |
| 18927321 | SYSTEMS AND METHODS FOR MONITORING AND CONTROLLING ADDITIVE PRINTING PROCESSES | TROCHE, EDGAREDMANUE | — |
| 18851829 | CYTOCOMPATIBLE HYDROGELS AND METHODS OF MAKING AND USING THE SAME | VASISTH, VISHAL V | — |
| 18890423 | MYC-HSF1 DUAL AMPLIFICATION AS A BIOMARKER FOR CANCER TREATMENT | GREENE, CAROLYN LEE | — |
| 18886296 | METHOD AND APPARATUS FOR ENCODING/DECODING NEURAL NETWORK-BASED PERSONALIZED SPEECH | VO, HUYEN X | — |
| 18794321 | METHODS TO TREAT RENAL DISORDERS USING CALCIUM CHANNEL INHIBITORS | WELLS, LAUREN QUINLAN | — |
| Art Unit | Apps |
|---|---|
| 1681 | 2 |
| 1636 | 2 |
| 3794 | 1 |
| 1614 | 1 |
| 1744 | 1 |
| 3772 | 1 |
| 1771 | 1 |
| 2656 | 1 |
| 1622 | 1 |
| 1638 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19083739 | HAND-HELD MEASUREMENT APPARATUS, SYSTEMS, AND METHODS | SARCENO ROBLES, CHRISTIAN MANUEL | 3794 | §102§103§112 | Non-Final OA | — | Pending | Mar 19, 2025 |
| 18861236 | THERAPEUTIC STRATEGIES TO MANAGE FACIAL CONTRACTURES POST INJURY | LIU, TRACY | 1614 | §103§112 | Non-Final OA | — | Pending | Oct 29, 2024 |
| 18927321 | SYSTEMS AND METHODS FOR MONITORING AND CONTROLLING ADDITIVE PRINTING PROCESSES | TROCHE, EDGAREDMANUE | 1744 | §102§103§112 | Non-Final OA | — | Pending | Oct 25, 2024 |
| 18913249 | DENTAL IMPLANTS, DENTAL ASSEMBLIES, AND METHODS OF IMPLANTING AND REPAIRING DENTAL ASSEMBLIES | MORAN, EDWARD JOHN | 3772 | §112 | Final Rejection | 33d | Pending | Oct 11, 2024 |
| 18851829 | CYTOCOMPATIBLE HYDROGELS AND METHODS OF MAKING AND USING THE SAME | VASISTH, VISHAL V | 1771 | §103DP | Non-Final OA | — | Pending | Sep 27, 2024 |
| 18890423 | MYC-HSF1 DUAL AMPLIFICATION AS A BIOMARKER FOR CANCER TREATMENT | GREENE, CAROLYN LEE | 1681 | §101§103§112DP | Non-Final OA | — | Pending | Sep 19, 2024 |
| 18886296 | METHOD AND APPARATUS FOR ENCODING/DECODING NEURAL NETWORK-BASED PERSONALIZED SPEECH | VO, HUYEN X | 2656 | §103 | Final Rejection | — | Pending | Sep 16, 2024 |
| 18794321 | METHODS TO TREAT RENAL DISORDERS USING CALCIUM CHANNEL INHIBITORS | WELLS, LAUREN QUINLAN | 1622 | §102 | Non-Final OA | — | Pending | Aug 05, 2024 |
| 18835051 | A METHOD FOR RAPID GENERATION OF 3D ORGANOTYPIC CELL CLUSTERS | JACKSON III, WALTER | 1638 | §103 | Non-Final OA | — | Pending | Aug 01, 2024 |
| 18720033 | CELL TARGETING COMPOSITIONS AND METHODS | AEDER, SEAN E | 1642 | §112 | Non-Final OA | — | Pending | Jun 14, 2024 |
| 18716889 | METHODS OF GENERATING HUMAN COCHLEAR HAIR CELLS | ZHU, JIANJIAN | 1631 | §103§112 | Non-Final OA | — | Pending | Jun 05, 2024 |
| 18699774 | METHOD OF REGULATING PULMONARY ARTERY VASCULAR REMODELING | POLIAKOVA-GEORGAN, EKATERINA | 1637 | §102§103§112 | Non-Final OA | — | Pending | Apr 09, 2024 |
| 18694650 | DEPLETION OF FNDC5 REDUCES CANCER INDUCED MUSCLE LOSS/CACHEXIA | CHONG, KIMBERLY | 1636 | §102§112 | Non-Final OA | — | Pending | Mar 22, 2024 |
| 18691513 | ZWITTERIONIC SURFACES FOR LOCALIZED SURFACE PLASMON RESONANCE | RILEY, JEZIA | 1681 | §102§103§112 | Non-Final OA | — | Pending | Mar 13, 2024 |
| 18688475 | COMPOSITION AND METHOD TO TREAT CACHEXIA | DACE DENITO, ALEXANDRA GERALDINE | 1636 | §102§103§112 | Non-Final OA | — | Pending | Mar 01, 2024 |
| 18687205 | COMPOSITIONS AND METHODS TO TREAT SKIN DISORDERS | VALLE, ERNESTO | 1623 | §103 | Non-Final OA | — | Pending | Feb 27, 2024 |
| 18575429 | CXC CHEMOKINE AGONISTS AND ANTAGONISTS IN COVID-19 DISEASE AND DIAGNOSTIC ASSAYS | KATAKAM, SUDHAKAR | 1658 | §103 | Non-Final OA | — | Pending | Dec 29, 2023 |
| 18262798 | PHARMACEUTICAL COMPOSITIONS AND THEIR METHODS OF USE | BOECKELMAN, JACOB A | 1655 | §101§102§103 | Final Rejection | — | Pending | Dec 21, 2023 |
| 18541121 | POTENTIATING THE TUMOR-SELECTIVE EFFECTS OF NQO1-BIOACTIVATABLE AGENT BY USE OF CMET INHIBITOR | ARCORIA, PAUL JOSEPH | 1621 | §102§103§112 | Non-Final OA | 28d | Pending | Dec 15, 2023 |
| 18535605 | ULTRA-HIGH SPECIFIC ENERGY CATHODE MATERIALS FOR LITHIUM-ION BATTERIES AND METHODS FOR PRODUCING THE SAME | RASSOULI, LILI | 1728 | §103§112 | Non-Final OA | — | Pending | Dec 11, 2023 |
| 18261451 | METHODS TO PREDICT EFFECTS OF PERIOPERATIVE ADMINISTRATION OF METHADONE TO OPTIMIZE PAIN RELIEF AND AVOID ADVERSE EFFECTS | GOLDBERG, JEANINE ANNE | 1682 | §101§103§112 | Non-Final OA | — | Pending | Jul 13, 2023 |
| 18033229 | MOLECULAR DESIGNS OF GLUCOSE-RESPONSIVE AND GLUCOSE-CLEAVABLE INSULIN ANALOGUES | BOWLES, DAVID PAUL | 1654 | §112 | Non-Final OA | 28d | Pending | Apr 21, 2023 |
| 18041241 | QUORUM SENSING INHIBITORS AND METHODS OF USE | OTTON, ALICIA L | 1699 | §102 | Non-Final OA | — | Pending | Feb 10, 2023 |
| 18040834 | IN VIVO LYMPHOVENOUS ANASTOMOSIS | SHIN, DANA H | 1635 | §103§112 | Final Rejection | 9d | Pending | Feb 07, 2023 |
| 17966286 | MAPPING CRITICAL BRAIN SITES USING INTRACRANIAL ELECTROPHYSIOLOGY AND MACHINE LEARNING | JASANI, ASHISH SHIRISH | 3798 | §103 | Non-Final OA | — | Pending | Oct 14, 2022 |
| 17937136 | SEI PREFORMED GRAPHITE AND ASSOCIATED METHODS, APPARATUS, AND PRODUCTS | JACOBSON, SARAH JORDAN | 1785 | §103 | Non-Final OA | — | Pending | Sep 30, 2022 |
| 17870785 | N-PROPANOL/H2O MIXED SOLVENT COMPOSITIONS FOR MEMBRANE ELECTRODE ASSEMBLIES | LYNCH, VICTORIA HOM | 1724 | §103 | Final Rejection | 163d overdue | Pending | Jul 21, 2022 |
| 17791981 | SYSTEM AND METHOD FOR PROCESSING VIRUS PREPARATIONS TO REDUCE HETEROGENEITY | SIFFORD, JEFFREY MARK | 1671 | §103§112 | Final Rejection | 16d | Pending | Jul 11, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialThe Trustees of Indiana University has 28 pending office actions as of October 2026, spread across 26 art units and 28 examiners.
Christian Manuel Sarceno Robles has the most, with 1 of The Trustees of Indiana University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
